|
March 2021 |
COVID-19 Vaccination for Individuals with Allergic or Hypersensitivity Disorder *new*
Consensus Statement on COVID-19 Vaccination by Section of Clinical Immunologists and Allergists, College of Physicians, Singapore |
 |
|
March 2021 |
COVID-19 Vaccination on Benign Haematological Conditions*new*
Consensus Statement on COVID-19 Vaccination by Chapter of Haematologists, College of Physicians, Singapore |
|
|
March 2021 |
COVID-19 Vaccination for Patients with Cardiovascular Diseases *new*
Consensus Statement on COVID-19 Vaccination by Chapter of Cardiologists, College of Physicians, Singapore |
|
|
March 2021 |
COVID-19 Vaccination for People with Rheumatic Disease *new*
Consensus Statement on COVID-19 Vaccination by Chapter of Rheumatologists, College of Physicians, Singapore |
|
|
March 2021 |
COVID-19 Vaccination for Cancer Patients *new*
Consensus Statement on COVID-19 Vaccination by Chapter of Medical Oncologists, College of Physicians, Singapore |
|
|
September 2020 |
PRAS Guidelines - Resumption of Services after COVID-19 Circuit Breaker Period
COVID-19 is an unprecedented global health crisis which has severely impacted both the economy and everyday life. Locally, to combat its spread and contain the SARSCoV- 2 virus, the Singapore government’s Multi-Ministry Taskforce (MMT) instituted a ‘Circuit Breaker’ (CB) period which started on 7 April 2020. |
|
|
June 2020 |
FAQs from COVID-19 Webinar - The Singapore Experience (Part II)
Responses by Ministry of Health, Singapore |
|
|
June 2020 |
FAQs from COVID-19 Webinar - The Singapore Experience (Part II)
Responses by Chapter of Infectious Disease Physicians, College of Physicians, Singapore |
|
|
June 2020 |
Joint Statement from NCID & Chapter of ID - Interim Treatment Guidelines for COVID-19 *updated* Jan 4th 2021
As of 11th February 2020, the World Health Organisation has officially named the disease “COVID-19”. and the causative agent, “SARS-CoV-2”. This guideline provides updated interim evidence-based recommendations on the therapeutic management of patients with COVID-19 in Singapore, from our initial guidance issued on 2 April 2020. |
|
|
May 2020 |
Chapter of Pain Medicine Physicians Statement - Pain Procedures During Covid-19 Pandemic
There is a need to recognize that many patients suffering from pain may deteriorate functionally should pain not be addressed in a timely and appropriate manner. With the rapidly evolving COVID-19 pandemic situation, there is a need to weigh the risks and benefits of performing a pain procedure should the patient require it medically [1]. The general aims should be to alleviate severe pain, avoid significant deterioration of function and avoid unnecessary reliance on opioids or emergency department (ED) visits/ admissions which would increase risk of exposure to COVID. |
|
|
May 2020 |
Remote Reporting Guidelines for Home/Offsite Reporting Using a Virtual Desktop Connection during COVID-19 Pandemic
This guidance represents a temporary relaxation of currently available radiology display and reporting guidance from other professional bodies, both international and local during the COVID-19 global pandemic. It serves to provision for telecommuting in all workplaces in order to curb the transmission of disease locally. |
|
|
May 2020 |
Joint Statement from NCID & Chapter of ID - Period of Infectivity to Inform Strategies for De-Isolation for COVID-19 Patients
This joint paper by the National Centre for Infectious Diseases (NCID) and the Chapter of Infectious Disease Physicians, Academy of Medicine, Singapore, seeks to set out the current understanding of the infectiousness of persons with COVID-19 infection, from epidemiologic, clinical and microbiologic data, and thence to inform de-isolation strategies. |
|
|
April 2020 |
Management of Inflammatory Bowel Disease Patients in Singapore During COVID-19 Pandemic
The inflammatory bowel diseases (IBD), ulcerative colitis and Crohn’s disease, are chronic inflammatory conditions which require long term treatment. There is no current data on whether IBD medications increase the risk of contracting SARS-CoV-2, or its complications. However, the morbidity related to undertreated IBD is important and any measures undertaken to alter the delivery of care to IBD patients should be balanced. It is important to maintain disease control during this pandemic without compromising patient safety. |
|
|
April 2020 |
Management of Inflammatory Bowel Disease Patients in Singapore During COVID-19 Pandemic (Malay Version) |
|
|
April 2020 |
Management of Inflammatory Bowel Disease Patients in Singapore During COVID-19 Pandemic (Chinese Version) |
|
|
April 2020 |
Chapter of Gastroenterologists Professional Guidance on Risk Mitigation for Gastrointestinal Endoscopy During COVID-19 Pandemic in Singapore
This paper aims to provide professional guidance to practising gastrointestinal (GI) endoscopists for the safe conduct of GI endoscopy procedures during the current coronavirus disease 2019 (COVID-19) pandemic and future outbreaks of similar severe respiratory tract infections in Singapore. It draws on the lessons learnt during the severe acute respiratory syndrome (SARS) epidemic and available published data concerning the COVID-19 pandemic. It addresses measures before, during and after endoscopy that must be considered for both noninfected and infected patients, and provides recommendations for practical implementation. |
|
|
April 2020 |
Summary of Key Actions in Response to COVID-19 by College of Ophthalmologists
The Coronavirus (COVID-19) outbreak is now a global pandemic. In Singapore, there are ongoing clusters of community spread. The College of Ophthalmologists, Singapore would like to share guidelines developed in the public healthcare institutions (PHI) clusters on maintaining access to ophthalmic care, whilst protecting staff and patients from the COVID-19 infection. |
|
|
April 2020 |
Chapter of Gastroenterologists Professional Guidance for Management of Patients with Liver Disease in Singapore during the COVID-19 Pandemic
This paper aims to provide professional guidance to clinicians who are managing patients with chronic liver disease during the current coronavirus disease 2019 (COVID-19) pandemic in Singapore. We reviewed and summarised the available relevant published data on liver disease in COVID-19 and the advisory statements that were issued by major professional bodies, such as the American Association for the Study of Liver Diseases and European Association for the Study of the Liver, contextualising the recommendations to our local situation. |
|
|
April 2020 |
CPD Bulletin: Infectious Disease and COVID-19 Articles
Accelerated by global connectivity, the newly discovered Sars CoV 2 virus has spread like wildfire from what was initially a distant problem in Wuhan to now being responsible for several clusters of community transmission in Singapore. |
|
|
April 2020 |
CSS Statement on Surgical Response During COVID-19 Pandemic
Surgeons and healthcare workers form the foundation of surgical care of our healthcare system. Healthcare workers now face a difficult clinical reality. With the rising risk of community transmission, both patients and surgeons run the risks of contracting the disease. As responsible healthcare workers, it is essential that the surgical community be well prepared for the rapidly evolving situation. We should do our best to reduce viral transmission. We should also look after our health and enhance our ability to care for our patients. |
|
|
April 2020 |
Management of Pregnancy and Birth in Women with COVID-19
Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus SARS-CoV-2 first identified in Wuhan City, China, in December 2019. This virus which causes illnesses ranging from the common cough to more severe infections in humans is spreading exponentially worldwide. As much is still unknown, current opinions regarding management of COVID-19 positive women in pregnancy may change with the arrival of new knowledge. |
|
